CoWin Biotech

CoWin Biotech is a national high-tech enterprise with independent intellectual property rights in the field of life sciences. It mainly engages in the research and production of high value-added, high-tech biological reagents, providing innovative biological products and services to users in life science research, genetic testing, and in vitro diagnostics. The company has been successively recognized as a national high-tech enterprise, a technology-oriented small and medium-sized enterprise in Jiangsu Province, a gazelle enterprise in Jiangsu Province, and a private science and technology enterprise in Jiangsu Province. The company has established a specialized, intensive technological innovation system capable of forming independent intellectual property rights, along with an open collaborative innovation platform, thereby building a complete R&D innovation system. Its product lines mainly include molecular diagnostic raw material enzymes, nucleic acid collection and preservatives, nucleic acid extraction kits, and molecular diagnostic test kits, breaking China's reliance on imported reagents for biological research and industry. Since the outbreak of COVID-19 in 2020, CoWin Biotech’s independently developed products such as virus sampling tubes, virus nucleic acid extraction kits, and SARS-CoV-2 nucleic acid detection kits have obtained relevant qualifications, including medical device registration certificates/filing certificates, EU CE certification, and U.S. FDA Emergency Use Authorization.